AdjuCor Raises €29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology

Disclaimer: reBEAT is a biventricular cardiac support device that avoids blood contact, which is currently exclusively used in clinical investigations and not yet available for sale.